1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Protein Detection
  • 1.2.3 DNA Detection
  • 1.2.4 Hybridization
  • 1.2.5 Biomarker
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Companion Diagnostic Tests Market Share by Application: 2020 VS 2026
  • 1.3.2 Pharmaceutical and Biotechnology Companies
  • 1.3.3 Medical Device Companies
  • 1.3.4 Research Institutes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostic Tests Market Perspective (2015-2026)
• 2.2 Global Companion Diagnostic Tests Growth Trends by Regions
  • 2.2.1 Companion Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Companion Diagnostic Tests Historic Market Share by Regions (2015-2020)
  • 2.2.3 Companion Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostic Tests Players by Market Size
  • 3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2015-2020)
  • 3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2015-2020)
• 3.2 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
• 3.4 Global Companion Diagnostic Tests Market Concentration Ratio
  • 3.4.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2019
• 3.5 Key Players Companion Diagnostic Tests Area Served
• 3.6 Key Players Companion Diagnostic Tests Product Solution and Service
• 3.7 Date of Enter into Companion Diagnostic Tests Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests Breakdown Data by Type (2015-2026)

• 4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2015-2020)
• 4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 Companion Diagnostic Tests Breakdown Data by Application (2015-2026)

• 5.1 Global Companion Diagnostic Tests Historic Market Size by Application (2015-2020)
• 5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Companion Diagnostic Tests Market Size (2015-2026)
• 6.2 North America Companion Diagnostic Tests Market Size by Type (2015-2020)
• 6.3 North America Companion Diagnostic Tests Market Size by Application (2015-2020)
• 6.4 North America Companion Diagnostic Tests Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Companion Diagnostic Tests Market Size (2015-2026)
• 7.2 Europe Companion Diagnostic Tests Market Size by Type (2015-2020)
• 7.3 Europe Companion Diagnostic Tests Market Size by Application (2015-2020)
• 7.4 Europe Companion Diagnostic Tests Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Companion Diagnostic Tests Market Size (2015-2026)
• 8.2 China Companion Diagnostic Tests Market Size by Type (2015-2020)
• 8.3 China Companion Diagnostic Tests Market Size by Application (2015-2020)
• 8.4 China Companion Diagnostic Tests Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Companion Diagnostic Tests Market Size (2015-2026)
• 9.2 Japan Companion Diagnostic Tests Market Size by Type (2015-2020)
• 9.3 Japan Companion Diagnostic Tests Market Size by Application (2015-2020)
• 9.4 Japan Companion Diagnostic Tests Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Companion Diagnostic Tests Market Size (2015-2026)
• 10.2 Southeast Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
• 10.3 Southeast Asia Companion Diagnostic Tests Market Size by Application (2015-2020)
• 10.4 Southeast Asia Companion Diagnostic Tests Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 F. Hoffman LA Roche Ltd.
  • 11.1.1 F. Hoffman LA Roche Ltd. Company Details
  • 11.1.2 F. Hoffman LA Roche Ltd. Business Overview
  • 11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
  • 11.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2015-2020))
  • 11.1.5 F. Hoffman LA Roche Ltd. Recent Development
• 11.2 QIAGEN, Illumina, Inc.
  • 11.2.1 QIAGEN, Illumina, Inc. Company Details
  • 11.2.2 QIAGEN, Illumina, Inc. Business Overview
  • 11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
  • 11.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.2.5 QIAGEN, Illumina, Inc. Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Abbott Business Overview
  • 11.3.3 Abbott Companion Diagnostic Tests Introduction
  • 11.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.3.5 Abbott Recent Development
• 11.4 Agilent Technologies, Inc.
  • 11.4.1 Agilent Technologies, Inc. Company Details
  • 11.4.2 Agilent Technologies, Inc. Business Overview
  • 11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
  • 11.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.4.5 Agilent Technologies, Inc. Recent Development
• 11.5 Genomic Health, Inc.
  • 11.5.1 Genomic Health, Inc. Company Details
  • 11.5.2 Genomic Health, Inc. Business Overview
  • 11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
  • 11.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.5.5 Genomic Health, Inc. Recent Development
• 11.6 BioMerieux SA, BioGenex
  • 11.6.1 BioMerieux SA, BioGenex Company Details
  • 11.6.2 BioMerieux SA, BioGenex Business Overview
  • 11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
  • 11.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.6.5 BioMerieux SA, BioGenex Recent Development
• 11.7 AGENDIA NV
  • 11.7.1 AGENDIA NV Company Details
  • 11.7.2 AGENDIA NV Business Overview
  • 11.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
  • 11.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.7.5 AGENDIA NV Recent Development
• 11.8 Siemens Healthcare GmBH
  • 11.8.1 Siemens Healthcare GmBH Company Details
  • 11.8.2 Siemens Healthcare GmBH Business Overview
  • 11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
  • 11.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.8.5 Siemens Healthcare GmBH Recent Development
• 11.9 Thermo Fisher Scientific, Inc.
  • 11.9.1 Thermo Fisher Scientific, Inc. Company Details
  • 11.9.2 Thermo Fisher Scientific, Inc. Business Overview
  • 11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
  • 11.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  • 11.9.5 Thermo Fisher Scientific, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Companion Diagnostic Tests Scope and Market Size
Companion Diagnostic Tests market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Protein Detection
DNA Detection
Hybridization
Biomarker
Others

Market segment by Application, split into
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes

Based on regional and country-level analysis, the Companion Diagnostic Tests market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Companion Diagnostic Tests market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
F. Hoffman LA Roche Ltd.
QIAGEN, Illumina, Inc.
Abbott
Agilent Technologies, Inc.
Genomic Health, Inc.
BioMerieux SA, BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific, Inc.